General Notices

• Notice of NIDCD Participation in PAR-21-251 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)" and PAR-21-252 Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
  (NOT-DC-23-007)
  National Institute on Deafness and Other Communication Disorders
  

• Notice of NHLBI Participation in PAR-23-067, Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
  (NOT-HL-23-084)
  National Heart, Lung, and Blood Institute
  

• NHLBI Notice of Availability of Frequently Asked Questions (FAQs) for NOT-HL-23-078 and NOT-HL-23-079 (CAROL Act)
  (NOT-HL-23-085)
  National Heart, Lung, and Blood Institute
  

• Request for Information (RFI) on the NIH Office of Disease Prevention Strategic Plan for Fiscal Years 20242028
  (NOT-OD-23-108)
  Office of Disease Prevention
  

Notice of Changes to Funding Opportunities

• Notice of Change to Application and Submission Information in RFA-AI-22-076, Consortium for Food Allergy Research: Clinical Research Center (U01 Clinical Trial Required)
  (NOT-AI-23-043)
  National Institute of Allergy and Infectious Diseases
  

• Notice of NIEHS Participation in PAR-23-122 "Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)"
  (NOT-ES-23-010)
  National Institute of Environmental Health Sciences
  

• Notice of Change to Award Budget in PAR-23-118 "National Centers for Cryoelectron Microscopy (R24 Clinical Trial Not Allowed)"
  (NOT-GM-23-039)
  National Institute of General Medical Sciences
  

• Notice of Change to Institutional Eligibility Criteria in PAR-22-250 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)"
  (NOT-GM-23-040)
  National Institute of General Medical Sciences
  

• Notice to Extend the Expiration Date of RFA-HG-22-004: Genome Research Experiences to Attract Talented Undergraduates into Genomic Fields to Enhance Diversity (R25 Clinical Trial Not Allowed)
  (NOT-HG-23-031)
  National Human Genome Research Institute
  

• Notice of Change to Funding Opportunity Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18)
  (NOT-HS-23-010)
  Agency for Healthcare Research and Quality
  

• Notice of Clarification to Eligibility Criteria for PAR-22-265 "Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)"
  (NOT-NS-23-080)
  National Institute of Neurological Disorders and Stroke
  

• Notice of Correction to Section IV. Application and Submission Information for RFA-NS-24-022 "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)"
  (NOT-NS-23-083)
  National Institute of Neurological Disorders and Stroke
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)
  (NOT-CA-23-057)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
  (NOT-CA-23-058)
  National Cancer Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
  (NOT-HG-23-028)
  National Human Genome Research Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: High Quality Reference Genomes (HQRG) (UM1 Clinical Trial Not Allowed)
  (NOT-HG-23-029)
  National Human Genome Research Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: Human Pangenome Coordinating Center (U41) Clinical Trial Not Allowed
  (NOT-HG-23-030)
  National Human Genome Research Institute
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplements to Study the Economics of Cancer Control in Low- and Middle-Income Countries (LMICs)
  (NOT-CA-23-052)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Leveraging glial cells to treat addiction
  (NOT-DA-24-006)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Promoting Language and Communication in Minimally Verbal/Non-Speaking Individuals with Autism
  (NOT-DC-23-009)
  National Institute on Deafness and Other Communication Disorders
  

• Notice of Special Interest (NOSI): Development of Innovative Informatics and Data Science Technologies, Tools, and Methods for Vision Research
  (NOT-EY-23-005)
  National Eye Institute
  

Funding Opportunities

• Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
  (PAR-23-114)
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
  (PAR-23-137)
  National Institute of General Medical Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  Office of the Director, NIH
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
  (PAR-23-141)
  National Eye Institute
  Application Receipt Date(s): May 01, 2023
  
  

• NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
  (PAR-23-162)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): May 07, 2026
  
  

• Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
  (PAR-23-164)
  National Institute of Mental Health
  National Institute on Aging
  Application Receipt Date(s): May 07, 2026
  
  

• Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)
  (PAR-23-165)
  National Institute of Mental Health
  National Institute on Aging
  Application Receipt Date(s): May 07, 2026
  
  

• Fundamental Research to Understand the Mechanisms of Neurotropic Virus-mediated Disease (R01 Clinical Trial Not Allowed)
  (RFA-AI-23-028)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): August 25, 2023
  
  

• Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
  (RFA-AR-24-003)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): September 12, 2023
  
  

• Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)
  (RFA-CA-23-033)
  National Cancer Institute
  Application Receipt Date(s): December 15, 2023
  
  

• BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)
  (RFA-DC-24-001)
  National Institute on Deafness and Other Communication Disorders
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R01 Clinical Trial Not Allowed)
  (RFA-DE-24-001)
  National Institute of Dental and Craniofacial Research
  National Cancer Institute
  Application Receipt Date(s): July 24, 2023
  
  

• Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R21 Clinical Trial Not Allowed)
  (RFA-DE-24-002)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): July 24, 2023
  
  

• Strategies for Responsibly Reporting Back Environmental Health and Non-Genomic Research Results (R01 Clinical Trial Optional)
  (RFA-ES-23-006)
  National Institute of Environmental Health Sciences
  National Human Genome Research Institute
  Office of the Director, NIH
  Application Receipt Date(s): June 15, 2023
  
  

• Implementing and Evaluating New Models for Delivering Comprehensive, Coordinated, Person-Centered Care to People with Long COVID (U18)
  (RFA-HS-23-012)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): June 13, 2023
  
  

• Developing Measures to Advance Quality in Mental Health Care Services (R01 Clinical Trial Not Allowed)
  (RFA-MH-23-265)
  National Institute of Mental Health
  Application Receipt Date(s): October 10, 2023
  
  

• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54 Clinical Trial Optional)
  (RFA-NS-24-022)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 15, 2023